Tuesday, March 20, 2012

Clinical endocannabinoid deficiency (CECD)

PubMed folks... it doesn't get much more reputable than that! National Institutes of Health... CONCLUSION: Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. (That's medical marijuana for you folks at home.) http://www.ncbi.nlm.nih.gov/pubmed/18404144

No comments:

Post a Comment